Jun 29, 2020 | Press Release
CARY, N.C., June 29, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology, rare diseases and other complex therapeutic areas, was selected by Karyopharm Therapeutics, Inc. as a specialty pharmacy provider for XPOVIO® (selinexor) for... Jun 22, 2020 | Press Release
CARY, N.C., June 22, 2020—Biologics by McKesson, an independent specialty pharmacy and patient services company specializing in oncology, rare diseases and other complex therapeutic areas, is pleased to announce that Brandon Tom, PharmD, was named its new general... Jun 2, 2020 | Press Release
CARY, N.C., June 2, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Deciphera Pharmaceuticals as a specialty pharmacy provider for QINLOCK™ (ripretinib) for the treatment of adult patients... Jun 1, 2020 | Press Release
CARY, N.C., June 1—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Eli Lilly and Company as a specialty pharmacy provider for RETEVMO™ (selpercatinib), the first drug approved by the U.S.... May 27, 2020 | Press Release
CARY, N.C., May 27, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, will be the exclusive specialty pharmacy provider for Pemazyre™ (pemigatinib), Incyte’s selective fibroblast growth factor receptor... May 8, 2020 | Press Release
CARY, N.C., May 8, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Immunomedics, Inc. as a specialty pharmacy provider for TRODELVY™ (sacituzumab govitecan-hziy) for the treatment of... 